Related Experiment Video

Updated: Jun 16, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Whole-cell vaccines: A failure or a success waiting to happen?

John Copier1, Angus Dalgleish

  • 1Department of Oncology, St George's University of London, UK.

Current Opinion in Molecular Therapeutics
|February 9, 2010
PubMed

Insights

Whole-cell cancer vaccines show promise in early trials but face challenges in large phase III studies. Future research focuses on combination therapies to improve antitumor immunity.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Research

Background:

  • Whole-cell vaccination has shown efficacy in early-phase clinical trials for cancer treatment.
  • Recent high-profile phase III trials have unfortunately failed to meet their endpoints.
  • This includes trials of GVAX technologies by Cell Genesys.

Purpose of the Study:

  • To discuss potential reasons for the failure of selected phase III whole-cell vaccination trials.
  • To summarize the current status of whole-cell vaccination, focusing on recent trials.
  • To identify key measures for improving the generation of effective antitumor immunity.

Main Methods:

  • Review of recent phase III clinical trial data for whole-cell cancer vaccines.
  • Analysis of potential factors contributing to trial failures.
  • Exploration of emerging paradigms in cancer vaccine research, including combination therapies.

Main Results:

  • Several high-profile phase III trials have failed to meet predicted endpoints.
  • The review identifies potential reasons for these failures.
  • New approaches, such as combination therapies, are emerging.

Conclusions:

  • Whole-cell vaccination strategies require further refinement to achieve success in phase III trials.
  • Combination therapies incorporating immune modulators with standard treatments show promise.
  • Improvements in vaccine design and delivery are crucial for generating effective antitumor immunity.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview